GBA Biomarker Services

About Nextcea

Nextcea is a privately held, revenue-generating biotech services company founded in 2006 (contradicting some data showing 2018) and headquartered in Woburn, Massachusetts. It operates a specialized contract research model, providing biomarker quantification and analytical services to support drug development, primarily in neurodegenerative diseases and oncology. The company possesses proprietary biomarker panels and a technology platform centered on UPLC-MS/MS, and it engages in active intellectual property litigation to protect its assets. Its strategy is built on deep scientific expertise in specific biological pathways and collaborations with major research foundations.

Therapeutic Areas